Comments on: FDA Approves GSK Myelofibrosis Med That Has Edge Over Others in Drug Class

Comments on: FDA Approves GSK Myelofibrosis Med That Has Edge Over Others in Drug Class https://medcitynews.com/2023/09/fda-drug-approval-gsk-myelofibrosis-jak-inhibitor-ojjaara/ Healthcare technology news, life science current events Wed, 20 Sep 2023 17:53:53 +0000 hourly 1 https://wordpress.org/?v=6.3.1